167 related articles for article (PubMed ID: 10901301)
1. The interaction of chalcones with tubulin.
Lawrence NJ; McGown AT; Ducki S; Hadfield JA
Anticancer Drug Des; 2000 Apr; 15(2):135-41. PubMed ID: 10901301
[TBL] [Abstract][Full Text] [Related]
2. Cellular targets of the anti-breast cancer agent Z-1,1-dichloro-2,3-diphenylcyclopropane: type II estrogen binding sites and tubulin.
ter Haar E; Hamel E; Balachandran R; Day BW
Anticancer Res; 1997; 17(3C):1861-9. PubMed ID: 9216636
[TBL] [Abstract][Full Text] [Related]
3. Potent antimitotic and cell growth inhibitory properties of substituted chalcones.
Ducki S; Forrest R; Hadfield JA; Kendall A; Lawrence NJ; McGown AT; Rennison D
Bioorg Med Chem Lett; 1998 May; 8(9):1051-6. PubMed ID: 9871706
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, dimerization, and biological activity of hexaoxygenated chalcones related to calythropsin and combretastatins.
Seguin E; Elomri A; Magiatis P; Skaltsounis AL; Chao LR; Tillequin F
Nat Prod Lett; 2002 Jun; 16(3):187-93. PubMed ID: 12049219
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis through tubulin inhibition in human cancer cells by new chromene-based chalcones.
Aryapour H; Riazi GH; Ahmadian S; Foroumadi A; Mahdavi M; Emami S
Pharm Biol; 2012 Dec; 50(12):1551-60. PubMed ID: 22984888
[TBL] [Abstract][Full Text] [Related]
7. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C
J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907
[TBL] [Abstract][Full Text] [Related]
8. Effects of alpha-substitutions on structure and biological activity of anticancer chalcones.
Lawrence NJ; Patterson RP; Ooi LL; Cook D; Ducki S
Bioorg Med Chem Lett; 2006 Nov; 16(22):5844-8. PubMed ID: 16949281
[TBL] [Abstract][Full Text] [Related]
9. Chalcones: a new class of antimitotic agents.
Edwards ML; Stemerick DM; Sunkara PS
J Med Chem; 1990 Jul; 33(7):1948-54. PubMed ID: 2362275
[TBL] [Abstract][Full Text] [Related]
10. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164
[TBL] [Abstract][Full Text] [Related]
11. Novel benzylidene-9(10H)-anthracenones as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Prinz H; Ishii Y; Hirano T; Stoiber T; Camacho Gomez JA; Schmidt P; Düssmann H; Burger AM; Prehn JH; Günther EG; Unger E; Umezawa K
J Med Chem; 2003 Jul; 46(15):3382-94. PubMed ID: 12852768
[TBL] [Abstract][Full Text] [Related]
12. Phenylpropiophenone derivatives as potential anticancer agents: synthesis, biological evaluation and quantitative structure-activity relationship study.
Ivković BM; Nikolic K; Ilić BB; Žižak ŽS; Novaković RB; Čudina OA; Vladimirov SM
Eur J Med Chem; 2013 May; 63():239-55. PubMed ID: 23501110
[TBL] [Abstract][Full Text] [Related]
13. Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity.
Buey RM; Barasoain I; Jackson E; Meyer A; Giannakakou P; Paterson I; Mooberry S; Andreu JM; Díaz JF
Chem Biol; 2005 Dec; 12(12):1269-79. PubMed ID: 16356844
[TBL] [Abstract][Full Text] [Related]
14. Effects of a combretastatin A4 analogous chalcone and its Pt-complex on cancer cells: A comparative study of uptake, cell cycle and damage to cellular compartments.
Zoldakova M; Kornyei Z; Brown A; Biersack B; Madarász E; Schobert R
Biochem Pharmacol; 2010 Nov; 80(10):1487-96. PubMed ID: 20709029
[TBL] [Abstract][Full Text] [Related]
15. The concise synthesis of chalcone, indanone and indenone analogues of combretastatin A4.
Kerr DJ; Hamel E; Jung MK; Flynn BL
Bioorg Med Chem; 2007 May; 15(9):3290-8. PubMed ID: 17360188
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative activity and mechanism of action of DZ-3358, a novel pyrimidinyl pyrazole derivative.
Iwahana M; Ochi Y; Ejima A
Anticancer Res; 2000; 20(2A):785-92. PubMed ID: 10810355
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activity and cytostatic mechanism of novel 2-arylbenzo[b]furans.
Yang H; Pang JY; Cai YC; Xu ZL; Xian LJ
J Pharm Pharmacol; 2006 Sep; 58(9):1281-7. PubMed ID: 16945188
[TBL] [Abstract][Full Text] [Related]
18. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, cytotoxicity, and inhibitory effects on tubulin polymerization of a new 3-heterocyclo substituted 2-styrylquinazolinones.
Raffa D; Edler MC; Daidone G; Maggio B; Merikech M; Plescia S; Schillaci D; Bai R; Hamel E
Eur J Med Chem; 2004 Apr; 39(4):299-304. PubMed ID: 15072839
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase and microtubules as targets for the synthesis of releasable conjugate compounds.
Passarella D; Comi D; Vanossi A; Paganini G; Colombo F; Ferrante L; Zuco V; Danieli B; Zunino F
Bioorg Med Chem Lett; 2009 Nov; 19(22):6358-63. PubMed ID: 19833515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
